Excluded or Cautioned Populations in Phase 3 Trials Phase 3 REDEFINE/REIMAGINE protocols typically excluded participants with: Type 1 diabetes
It requires cardiovascular monitoring and is contraindicated in uncontrolled hypertension
The hallmark symptom of acute pancreatitis is severe, persistent abdominal pain , typically described as: Located in the upper abdomen (epigastric or left upper quadrant) Radiating to the back in approximately 50% of cases, often described as a "band-like" distribution Sudden in onset and constant in nature, rather than colicky Worsening after eating , particularly after fatty meals Not relieved by simple analgesia or changes in position Accompanying symptoms frequently include: Nausea and vomiting that may be persistent and severe Fever and tachycardia as systemic inflammatory responses develop Abdominal distension and tenderness on examination Jaundice (in cases associated with gallstones or biliary obstruction) Signs of systemic compromise such as hypotension, confusion, or reduced urine output in severe cases Patients should be specifically counselled that these symptoms differ from the common gastrointestinal side effects of tirzepatide, such as mild nausea, occasional vomiting, or transient abdominal discomfort, which typically occur early in treatment and resolve spontaneously
Effect of high-dose intravenous vitamin C on inflammation in cancer patients
Sterile water can be used but shortens reconstituted peptide shelf life to 72 hours versus 28 days with bacteriostatic water
